← Eichor
Study identifier: NCT05662371 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Influence of Nociception Level Monitor (NOL) Guided Analgesic Delivery on Robot-assisted Colorectal Surgery

Condition: Opioid Use, Unspecified · Pain, Postoperative  ·  Sponsor: University of Southern Denmark

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Being relatively new, the NOL monitor may offer interesting observations in perioperative nociception levels and appropriate analgesic consumption in diverse surgeries, including robot-assisted surgery. These observations may supplement the current efforts towards further advantages in rapid restitution. Therefore, the investigators planned a trial where intra-operative analgesics were guided using an NOL monitor to study if intra-operative NOL guidance influences peri-operative analgesic consumption, postoperative length of stay and quality of recovery of patients subjected for robot-assisted surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Thomas Strøm  ·  +45 79 97 00 00  ·  thomas.strom@rsyd.dk

Rajesh Bhavsar  ·  +45 79 97 00 00  ·  Rajesh.prabhakar.Bhavsar@rsyd.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Anaesthesiology and Intensive Care Research UnitAabenraa, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05662371